This trial looks at two ways to control pain after surgery, and whether one is better than the other at reducing pain and the need for pain medication.
1 Primary · 5 Secondary · Reporting Duration: 24-48 hours
2 Treatment Groups
1 of 2
Pecs II block
1 of 2
160 Total Participants · 2 Treatment Groups
Primary Treatment: Pecs II block · No Placebo Group · Phase 4
Who is running the clinical trial?
Age 18 - 75 · All Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What is the participant enrollment size of this investigation?
"Affirmative. The online resource clinicaltrials.gov indicates that this research project, first posted on July 14th 2021, is actively recruiting participants. 160 patients need to be identified from a single medical site." - Anonymous Online Contributor
What qualifications are needed to participate in this research project?
"This clinical research is seeking 160 individuals with tendonitis, aged 18-75. To quality for the study, prospective participants must be within this age range and have already undergone shoulder arthroscopy with open subpectoral biceps tenodesis." - Anonymous Online Contributor
Does this trial cater to participants younger than thirty years of age?
"This clinical trial has set a lower age limitation of 18 and an upper limit of 75 for patient enrollment, in compliance with the stated criteria." - Anonymous Online Contributor
Are participants currently being recruited for this research project?
"Affirmative. Clinicaltrials.gov's records indicate that this trial is currently recruiting participants, having been first posted on July 14th 2021 and recently updated on June 14th 2022. The study aims to include 160 patients from a single site of research." - Anonymous Online Contributor
What potential harms could result from a Pecs II block procedure?
"Our team has assigned Pecs II block a score of 3, as it is in its fourth phase and thus already approved for use." - Anonymous Online Contributor